FDA Draft ‘Guidance’ Would Allow Drug Makers To Distribute To Physicians Reprints Of Studies On Off-Label Uses Of Treatments
FDA might allow pharmaceutical and medical device companies to send physicians studies on off-label uses of medications, a move that “would be a break with the FDA’s prohibition on the marketing of drugs and medical devices for unapproved purposes,” the Washington Post reports. [click link for full article]
More: continued here
Filed under: Primary Care on December 6th, 2007